Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Submitted by
admin
on March 14, 2017 - 9:38am
Source:
Endpoints
News Tags:
Pfizer
Novartis
LEE011
Ibrance
ribociclib
Kisqali
breast cancer
Headline:
Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Do Not Allow Advertisers to Use My Personal information
